All Updates

All Updates

icon
Filter
Partnerships
23andMe and Nightingale Health collaborate for efficient blood testing and disease prediction
Precision Medicine
Jun 28, 2024
This week:
Product updates
ABL Space Systems' RS1 rocket damaged during preflight testing
Space Travel and Exploration Tech
Yesterday
Partnerships
Eve Air Mobility partners with Siemens to evaluate energy services for eVTOL aircraft
Passenger eVTOL Aircraft
Yesterday
Partnerships
Crisalion Mobility collaborates with Wilbur Air to operate Integrity eVTOL in Australia
Passenger eVTOL Aircraft
Yesterday
Partnerships
Supernal collaborates with Sigma Air Mobility to develop AAM Market
Passenger eVTOL Aircraft
Yesterday
Partnerships
SpaceX secures ~USD 113 million NASA contract for JPSS-4 mission
Next-gen Satellites
Yesterday
Partnerships
SpaceX secures ~USD 113 million NASA contract for JPSS-4 mission
Space Travel and Exploration Tech
Yesterday
Industry news
NASA advances space communications for lunar exploration
Space Travel and Exploration Tech
Yesterday
Industry news
Funding
Indian aerospace industry receives INR 10 billion budget to advance in space technology
Space Travel and Exploration Tech
Yesterday
Funding
Third Arc Bio raises USD 165 million in Series A funding to advance oncology and autoimmunity clinical programs
Precision Medicine
Yesterday
Partnerships
BostonGene collaborates with Sylvester Comprehensive Cancer Center to validate blood- and bone marrow-based assays for hematological cancers
Precision Medicine
Yesterday
Precision Medicine

Precision Medicine

Jun 28, 2024

23andMe and Nightingale Health collaborate for efficient blood testing and disease prediction

Partnerships

  • 23andMe has entered a strategic partnership with Nightingale Health to provide Nightingale Health's blood metabolomics panel to selected 23andMe members. The partnership aims to make blood testing more efficient, accessible, and informative.

  • The collaboration involves piloting Nightingale Health's clinically verified blood metabolomics panel with a cohort of 23andMe members to measure various biomarkers in a single blood sample. The data from this blood testing can enhance the accuracy of disease risk predictions and provide helpful insights into lifestyle interventions beneficial for a customer's health.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.